Oticon Medical’s Sentio™ System Approved for US Market
Oticon Medical announced today that the U.S. Food and Drug Administration (FDA) has approved its Sentio™ System, the company’s first active transcutaneous bone conduction hearing system. Offering enhanced features over the existing Ponto™ System, Sentio System includes the Sentio 1…
Talkspace, FlexIt Expand Wellness with Free NYC Fitness
Today, Talkspace, a leading online behavioral health care company, has announced a partnership with FlexIt, a top provider of virtual personal wellness services such as personal training, nutrition guidance, and yoga. Together, they will introduce a series of free outdoor…
Verastem Oncology Initiates Phase 1/2 Trial in China for KRAS G12D Inhibitor GFH375/VS-7375 with GenFleet
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the first patient has been dosed in a Phase 1/2 trial in China, conducted by GenFleet Therapeutics, evaluating GFH375/VS-7375, a KRAS…
72 Million U.S. Women Have Postponed Essential Screenings
A recent survey by Hologic, Inc., reveals that a significant number of American women have postponed or skipped crucial health screenings, despite acknowledging their importance. This national study, conducted by Gallup on behalf of Hologic, underscores a concerning “Screening Action…
Endoron Medical Raises $10M to Accelerate Validation of AAA EndoStapling Solution
Endoron Medical, a pioneering medtech firm specializing in innovative endograft stapling solutions for abdominal aortic aneurysms (AAA), has successfully closed a $10 million Series A funding round. Sofinnova Partners led the round, with substantial contributions from the European Innovation Council…
CareAtHome & Vesta Healthcare Chosen for Medicare Dementia Care Model Test
CareAtHome Medical Group, alongside Vesta Healthcare, has been chosen by the Centers for Medicare & Medicaid Services (CMS) to participate in the innovative GUIDE Model, starting July 2025. This Medicare alternative payment model aims to support individuals with dementia and…
Galderma Launches Cetaphil Serums for Sensitive Skin
Galderma has announced the U.S. exclusive launch of two new innovations in its Cetaphil product line: the Vitamin C Serum and the Ceramide Serum. According to clinical studies, the Cetaphil Vitamin C Serum has shown impressive results: 95% of participants…
Genentech Reintroduces Susvimo for Wet AMD
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant in the United States (U.S.) for the treatment of individuals with wet,…
Element Science Wins Red Dot Award for Jewel® Patch Defibrillator
Element Science, a leader in health technology, has proudly announced that its Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) has been honored with the prestigious Red Dot Design Award. This recognition underscores Jewel’s exceptional design, focused on patient comfort and continuous…
Pint Pharma’s ORLADEYO® Approved to Prevent HAE Attacks in Peru
Pint Pharma is pleased to announce that ORLADEYO® (berotralstat) has been approved by the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru for daily oral use in the prophylaxis of hereditary angioedema (HAE) attacks in adult and pediatric…
Amplar Home Health Unveils Innovative Adelaide Headquarter
Amplar Home Health, a leading provider of in-home care services in Australia, has unveiled its new headquarters in Adelaide. This purpose-built facility represents a significant step forward in Amplar Health’s mission to innovate healthcare delivery across the country. The Hon.…
Chemed’s Q2 2024 Earnings Report Set for July 24, Conference Call on July 25
Chemed Corporation (NYSE: CHE) announced today that it will release its financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, after the close of trading on the New York Stock Exchange. Following the release,…